Effect of a Remotely Delivered Weight Loss Intervention in Early-Stage Breast Cancer: Randomized Controlled Trial

Limited evidence exists on the effects of weight loss on chronic disease risk and patient-reported outcomes in breast cancer survivors. Breast cancer survivors (stage I–III; body mass index 25–45 kg/m<sup>2</sup>) were randomized to a 12-month, remotely delivered (22 telephone calls, mai...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marina M. Reeves, Caroline O. Terranova, Elisabeth A. H. Winkler, Nicole McCarthy, Ingrid J. Hickman, Robert S. Ware, Sheleigh P. Lawler, Elizabeth G. Eakin, Wendy Demark-Wahnefried
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/2023d5e75de347d2836babf2431922f2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2023d5e75de347d2836babf2431922f2
record_format dspace
spelling oai:doaj.org-article:2023d5e75de347d2836babf2431922f22021-11-25T18:36:41ZEffect of a Remotely Delivered Weight Loss Intervention in Early-Stage Breast Cancer: Randomized Controlled Trial10.3390/nu131140912072-6643https://doaj.org/article/2023d5e75de347d2836babf2431922f22021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6643/13/11/4091https://doaj.org/toc/2072-6643Limited evidence exists on the effects of weight loss on chronic disease risk and patient-reported outcomes in breast cancer survivors. Breast cancer survivors (stage I–III; body mass index 25–45 kg/m<sup>2</sup>) were randomized to a 12-month, remotely delivered (22 telephone calls, mailed material, optional text messages) weight loss (diet and physical activity) intervention (<i>n</i> = 79) or usual care (<i>n</i> = 80). Weight loss (primary outcome), body composition, metabolic syndrome risk score and components, quality of life, fatigue, musculoskeletal pain, menopausal symptoms, fear of recurrence, and body image were assessed at baseline, 6 months, 12 months (primary endpoint), and 18 months. Participants were 55 ± 9 years and 10.7 ± 5.0 months post-diagnosis; retention was 81.8% (12 months) and 80.5% (18 months). At 12-months, intervention participants had significantly greater improvements in weight (−4.5% [95%CI: −6.5, −2.5]; <i>p</i> < 0.001), fat mass (−3.3 kg [−4.8, −1.9]; <i>p</i> < 0.001), metabolic syndrome risk score (−0.19 [−0.32, −0.05]; <i>p</i> = 0.006), waist circumference (−3.2 cm [−5.5, −0.9]; <i>p</i> = 0.007), fasting plasma glucose (−0.23 mmol/L [−0.44, −0.02]; <i>p</i> = 0.032), physical quality of life (2.7 [0.7, 4.6]; <i>p</i> = 0.007; Cohen’s effect size (<i>d</i>) = 0.40), musculoskeletal pain (−0.5 [−0.8, −0.2]; <i>p</i> = 0.003; <i>d</i> = 0.49), and body image (−0.2 [−0.4, −0.0]; <i>p</i> = 0.030; <i>d</i> = 0.31) than usual care. At 18 months, effects on weight, adiposity, and metabolic syndrome risk scores were sustained; however, significant reductions in lean mass were observed (−1.1 kg [−1.7, −0.4]; <i>p</i> < 0.001). This intervention led to sustained improvements in adiposity and metabolic syndrome risk.Marina M. ReevesCaroline O. TerranovaElisabeth A. H. WinklerNicole McCarthyIngrid J. HickmanRobert S. WareSheleigh P. LawlerElizabeth G. EakinWendy Demark-WahnefriedMDPI AGarticleobesityexercisenutritionsupportive caresurvivorshiptelehealthNutrition. Foods and food supplyTX341-641ENNutrients, Vol 13, Iss 4091, p 4091 (2021)
institution DOAJ
collection DOAJ
language EN
topic obesity
exercise
nutrition
supportive care
survivorship
telehealth
Nutrition. Foods and food supply
TX341-641
spellingShingle obesity
exercise
nutrition
supportive care
survivorship
telehealth
Nutrition. Foods and food supply
TX341-641
Marina M. Reeves
Caroline O. Terranova
Elisabeth A. H. Winkler
Nicole McCarthy
Ingrid J. Hickman
Robert S. Ware
Sheleigh P. Lawler
Elizabeth G. Eakin
Wendy Demark-Wahnefried
Effect of a Remotely Delivered Weight Loss Intervention in Early-Stage Breast Cancer: Randomized Controlled Trial
description Limited evidence exists on the effects of weight loss on chronic disease risk and patient-reported outcomes in breast cancer survivors. Breast cancer survivors (stage I–III; body mass index 25–45 kg/m<sup>2</sup>) were randomized to a 12-month, remotely delivered (22 telephone calls, mailed material, optional text messages) weight loss (diet and physical activity) intervention (<i>n</i> = 79) or usual care (<i>n</i> = 80). Weight loss (primary outcome), body composition, metabolic syndrome risk score and components, quality of life, fatigue, musculoskeletal pain, menopausal symptoms, fear of recurrence, and body image were assessed at baseline, 6 months, 12 months (primary endpoint), and 18 months. Participants were 55 ± 9 years and 10.7 ± 5.0 months post-diagnosis; retention was 81.8% (12 months) and 80.5% (18 months). At 12-months, intervention participants had significantly greater improvements in weight (−4.5% [95%CI: −6.5, −2.5]; <i>p</i> < 0.001), fat mass (−3.3 kg [−4.8, −1.9]; <i>p</i> < 0.001), metabolic syndrome risk score (−0.19 [−0.32, −0.05]; <i>p</i> = 0.006), waist circumference (−3.2 cm [−5.5, −0.9]; <i>p</i> = 0.007), fasting plasma glucose (−0.23 mmol/L [−0.44, −0.02]; <i>p</i> = 0.032), physical quality of life (2.7 [0.7, 4.6]; <i>p</i> = 0.007; Cohen’s effect size (<i>d</i>) = 0.40), musculoskeletal pain (−0.5 [−0.8, −0.2]; <i>p</i> = 0.003; <i>d</i> = 0.49), and body image (−0.2 [−0.4, −0.0]; <i>p</i> = 0.030; <i>d</i> = 0.31) than usual care. At 18 months, effects on weight, adiposity, and metabolic syndrome risk scores were sustained; however, significant reductions in lean mass were observed (−1.1 kg [−1.7, −0.4]; <i>p</i> < 0.001). This intervention led to sustained improvements in adiposity and metabolic syndrome risk.
format article
author Marina M. Reeves
Caroline O. Terranova
Elisabeth A. H. Winkler
Nicole McCarthy
Ingrid J. Hickman
Robert S. Ware
Sheleigh P. Lawler
Elizabeth G. Eakin
Wendy Demark-Wahnefried
author_facet Marina M. Reeves
Caroline O. Terranova
Elisabeth A. H. Winkler
Nicole McCarthy
Ingrid J. Hickman
Robert S. Ware
Sheleigh P. Lawler
Elizabeth G. Eakin
Wendy Demark-Wahnefried
author_sort Marina M. Reeves
title Effect of a Remotely Delivered Weight Loss Intervention in Early-Stage Breast Cancer: Randomized Controlled Trial
title_short Effect of a Remotely Delivered Weight Loss Intervention in Early-Stage Breast Cancer: Randomized Controlled Trial
title_full Effect of a Remotely Delivered Weight Loss Intervention in Early-Stage Breast Cancer: Randomized Controlled Trial
title_fullStr Effect of a Remotely Delivered Weight Loss Intervention in Early-Stage Breast Cancer: Randomized Controlled Trial
title_full_unstemmed Effect of a Remotely Delivered Weight Loss Intervention in Early-Stage Breast Cancer: Randomized Controlled Trial
title_sort effect of a remotely delivered weight loss intervention in early-stage breast cancer: randomized controlled trial
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/2023d5e75de347d2836babf2431922f2
work_keys_str_mv AT marinamreeves effectofaremotelydeliveredweightlossinterventioninearlystagebreastcancerrandomizedcontrolledtrial
AT carolineoterranova effectofaremotelydeliveredweightlossinterventioninearlystagebreastcancerrandomizedcontrolledtrial
AT elisabethahwinkler effectofaremotelydeliveredweightlossinterventioninearlystagebreastcancerrandomizedcontrolledtrial
AT nicolemccarthy effectofaremotelydeliveredweightlossinterventioninearlystagebreastcancerrandomizedcontrolledtrial
AT ingridjhickman effectofaremotelydeliveredweightlossinterventioninearlystagebreastcancerrandomizedcontrolledtrial
AT robertsware effectofaremotelydeliveredweightlossinterventioninearlystagebreastcancerrandomizedcontrolledtrial
AT sheleighplawler effectofaremotelydeliveredweightlossinterventioninearlystagebreastcancerrandomizedcontrolledtrial
AT elizabethgeakin effectofaremotelydeliveredweightlossinterventioninearlystagebreastcancerrandomizedcontrolledtrial
AT wendydemarkwahnefried effectofaremotelydeliveredweightlossinterventioninearlystagebreastcancerrandomizedcontrolledtrial
_version_ 1718410879571066880